HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Boros, D. L. Articles by Warren, K. S. Search for Related Content PubMed Articles by Boros, D. L. Articles by Warren, K. S.

Delayed Hypersensitivity, as Manifested by Granuloma Formation, Dermal Reactivity, Macrophage Migration Inhibition and Lymphocyte Transformation, Induced and Elicited in Guinea Pigs with Soluble Antigens of Schistosoma Mansoni Eggs¹

From the Departments of Preventive Medicine, Medicine, and Surgery, Case Western Reserve University School of Medicine, and University Hospitals, Cleveland, Ohio 44106

Abstract

Delayed hypersensitivity (DH) was induced in guinea pigs 3 to 6 days after immunization with microgram quantities of soluble antigens derived from Schistosoma mansoni eggs (SEA). Sensitization was achieved by incorporating SEA into complete Freund's adjuvant, but remarkably, animals could also be sensitized by intraperitoneally injected live eggs, or by direct injection of SEA alone into the footpad. DH was measured by comparing dermal and granulomatous reactivity in vivo and ³H-thymidine incorporation and macrophage migration inhibition (MI) in vitro. SEA could be employed successfully also for the elicitation of the different immune responses. The parameters appeared in parallel, MI preceding the rest by 1 day. Granuloma formation, which occurred within 24 hr in the lungs of sensitized animals, correlated well with other parameters of DH. During the 1st 10 days of immunization, when DH was already fully developed, ₁ or ₂ antibodies could not be detected in the circulation of immunized animals.

Footnotes

¹ This investigation was supported by the United States-Japan Cooperative Medical Science Program administered by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (Grant AI-31814-03), by the Cuyahoga County Unit of the American Cancer Society and United States Public Health Service Grant AM-01005, and by the Health Fund of Greater Cleveland. Portions of this work were presented at the 55th annual meeting of The Federation of American Societies for Experimental Biology, Chicago, Illinois, April 12–17, 1971 (Fed. Proc., 30: 351, 1971).